MDR Bacterial Infections Our Treatment Option

More documents

Recommendations

Info

FIC Index of <strong>MDR</strong> P. aeruginosaStrain no. 3 combo 2 combo1 0.0456 (S) 1.0 (A)2 0.0675 (S) 0.503 (PS)3 0.0756 (S) 1.03 (I)4 0.0378 (S) 0.75 (PS)5 0.2578 (S) 0.75 (PS)2 combo = meropenem + colistin3 combo = meropenem + colistin + fosfomycin (87.3 mg/L)
Pintip Pongpech, Suparak Amornnopparattanakul, Sakulthip Panapakdee, Siriporn Fungwithaya, Penphun Nannha, Chertsak Dhiraputra, Amorn Leelarasamee.Antibacterial activity of carbapenem-based combinations against multidrug-resistant Acinetobacter baumannii. J Med Assoc Thai 2010;93:161-71.
Page 1 and 2: MDR Bacterial Infections:Our Treatm
Page 5 and 6: IDSA News: 10 New Antibiotics by 20
Page 7 and 8: 60504030201001911102010719992000261
Page 9 and 10: Definition & Action of KPC, CRKP an
Page 11 and 12: Maria Souli, Irene Galani, Anastasi
Page 13 and 14: Antimicrobial Susceptibility for ND
Page 15 and 16: KPC-p K. pneumoniaeisolate. (USA)Ca
Page 18 and 19: MIC distributions of NDM-1 Enteroba
Page 20 and 21: Drug of Choice for ESBL-producingEn
Page 22 and 23: Antimicrobial Option by Risk Level
Page 24 and 25: In vitro activities of fosfomycin a
Page 26 and 27: 0.5, 1.0, 2.0-gm Human Simulated Pr
Page 28 and 29: FIC Index & InterpretationInterpret
Page 32 and 33: Population PharmacokineticAnalysis
Page 34 and 35: Attenuation of Colistin Bactericida
Page 36 and 37: Pharmacokinetic/Pharmacodynamic Det
Page 38 and 39: Recommended Definite Therapy for Se
Page 40 and 41: Breakpoint Criteria of Vancomycin f
Page 42 and 43: One Gram bid: Enough for Vancomycin
Page 44 and 45: การใชยา vancomycin
Page 46 and 47: ยาขนานอื่น ถ
Page 48 and 49: Early Combination Rx vs. Monotherap
Page 54: Thank youAny Comment?Any Question?

MDR Bacterial Infections Our Treatment Option

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?